Catalyst Wire Dossier Catalyst Wire Dossier

Dupilumab (Dupixent)

Dupilumab · Sanofi
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Dupilumab (Dupixent), covering 2022-07-22 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis [Phase 4]

See pricing